Peishan Hu
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 6
- Cancer, Lipids, and Metabolism 4
- MicroRNA in disease regulation 3
-
- RNA modifications and cancer 9
- RNA Research and Splicing 4
-
- Colorectal Cancer Treatments and Studies 3
-
- Genetic factors in colorectal cancer 3
-
- Ferroptosis and cancer prognosis 3
- Co-authors
- Zexian LiuHuai‐Qiang JuQi‐Nian WuRui‐Hua XuHeng‐Ying PuJin‐Fei LinXiaozhong PengTao Jiang
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Peishan Hu
28 papers receiving 827 citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Cancer Research 310
- Molecular Biology 564
- Oncology 172
- Immunology 98
- Genetics 45
Countries citing papers authored by Peishan Hu
This map shows the geographic impact of Peishan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peishan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peishan Hu more than expected).
Fields of papers citing papers by Peishan Hu
This network shows the impact of papers produced by Peishan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peishan Hu. The network helps show where Peishan Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peishan Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 12 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 15 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 24 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 7 | |
| 10 | 2022 | 36 | |
| 11 | 2021 | 59 | |
| 12 | 2020 | 46 | |
| 13 | 2019 | 1 | |
| 14 | 2019 | 33 | |
| 15 | 2019 | 50 | |
| 16 | 2019 | 42 | |
| 17 | 2019 | 1 | |
| 18 | 2019 | 39 | |
| 19 | 2018 | 1 | |
| 20 | 2018 | 27 |
About Peishan Hu
Peishan Hu is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 30 papers that have together received 832 indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), Cancer, Hypoxia, and Metabolism (6 papers), Cancer, Lipids, and Metabolism (4 papers), RNA Research and Splicing (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Genetic factors in colorectal cancer (3 papers), MicroRNA in disease regulation (3 papers) and Ferroptosis and cancer prognosis (3 papers). The work is most often cited by research in Cancer Research (310 citations), Molecular Biology (564 citations) and Oncology (172 citations). Peishan Hu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zexian Liu, Huai‐Qiang Ju, Qi‐Nian Wu, Rui‐Hua Xu, Heng‐Ying Pu, Jin‐Fei Lin, Xiaozhong Peng, Tao Jiang, Miao‐Zhen Qiu and Boqin Qiang. Their work appears in journals such as Journal of Clinical Investigation, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.